Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Chinese Pharmaceutical Journal ; (24): 960-964, 2012.
Article in Chinese | WPRIM | ID: wpr-860702

ABSTRACT

OBJECTIVE: To identify the characteristics of recombinant adenovirus modified PBMC-derived dendritic cells to resist the HIV-1 infection. METHODS: The recombinant adenovirus vector was integrated with CCR5A32, CCR5siRNA, HIV-1 poli and HIV-1 inti genes by using AdEasy system. The human PBMC from healthy donor blood was isolated in order to get dendritic cells. The expression of CCR5Δ32, CCR5, CXCR4 and HIV-1 P24 in PBMC or modified cells was measured by Westernblot. RESULTS: After the cells have been modified by Ad-R5Δ32siHIV, the expression of CCR5Δ32 was increased while the expression of CCR5 and CXCR4 were decreased. The level of p24 was lower in modified cells than that of unmodified cells. The modified cells show resistance to HIV-1 infection. CONCLUSION: The recombinant adenovirus-modified cells show good resistance to HIV-1 infection. Modification of HSC-derived immunity cells, such as DCs, may be a potent strategy to resist HIV-1 infection.

2.
Journal of Southern Medical University ; (12): 720-723, 2010.
Article in Chinese | WPRIM | ID: wpr-355035

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the inhibitory activities of caffeoyl glucopyranoses purified from Balanophora japonica Makino on HIV entry and their mechanism.</p><p><b>METHODS</b>HIV-1 Env pseudovirus was used to evaluate the anti-HIV-1 activity of those compounds. ELISA and molecular docking were used to study the mechanism of the actions of the active compounds.</p><p><b>RESULTS</b>We used the HIV-1 Env pseudovirus to test the anti-HIV-1 activity of the six phenolic compounds (final concentration 25 microg/ml), and found that only 1,2,6-Tri-O-caffeoyl-beta-D-glucopyranose (TCGP) and 1,3-Di-O-caffeoyl-4-O-galloyl-beta-D- glucopyranose (DCGGP) could effectively inhibit the entry of HIV-1 Env pseudovirus into the target cells in a dose-dependent manner, with IC(50) values of 5.5-/+0.2 and 5.3-/+0.1 microg/ml, respectively. These two compounds could also blocked the gp41 six-helix bundle formation. Molecular docking analysis suggested that they might bind to the hydrophobic cavity of the gp41 N-trimeric coiled-coil.</p><p><b>CONCLUSION</b>TCGP and DCGGP are potent HIV-1 entry inhibitors targeting gp41 and can serve as lead compounds for developing novel anti-HIV-1 microbicides for prevention of sexual HIV-1 transmission.</p>


Subject(s)
Humans , Anti-HIV Agents , Pharmacology , Balanophoraceae , Chemistry , Cell Line , Gallic Acid , Pharmacology , Glucose , Pharmacology , HIV-1 , Hydrolyzable Tannins , Pharmacology , Plant Extracts , Pharmacology
3.
Journal of Southern Medical University ; (12): 160-162, 2010.
Article in Chinese | WPRIM | ID: wpr-269601

ABSTRACT

<p><b>OBJECTIVE</b>To isolate the active component from Dioscorea cirrhosa Lour and test its activity in lowering blood pressure.</p><p><b>METHODS</b>The serial components were obtained from the total extract, ligroin extract, ethyl acetate, n-butyl alcohol extract and water extract. The isolated active components were administered in rats via the common carotid artery canulation and tail vein injection to test their effects on blood pressure.</p><p><b>RESULTS</b>The component A isolated and purified from normal butanol showed obvious effect in lowering the blood pressure of rats.</p><p><b>CONCLUSION</b>The isolated active component from Dioscorea cirrhosa Lour possesses obvious blood pressure-lowering activity.</p>


Subject(s)
Animals , Male , Rats , Antihypertensive Agents , Pharmacology , Blood Pressure , Dioscorea , Chemistry , Drugs, Chinese Herbal , Pharmacology , Plant Extracts , Pharmacology , Rats, Sprague-Dawley
4.
Journal of Southern Medical University ; (12): 941-944, 2010.
Article in Chinese | WPRIM | ID: wpr-290025

ABSTRACT

<p><b>OBJECTIVE</b>To develop an objective bioassay for quantitative detection of HIV-induced cell-cell fusion for screening HIV entry inhibitors.</p><p><b>METHODS</b>HL2/3 cells expressing HIV envelope proteins gp120/gp41, Tat, and other HIV proteins were co-cultured with HeLa-CD4-LTR-beta-gal cells expressing CD4 receptor and HIV LTR triggered reporter gene beta-galactosidase. The enzyme activities of beta-galactosidase were detected by a chromogenic substrate, chlorophenol red-beta-galactopyranoside (CPRG). Specific HIV entry inhibitors were used to validate the established detecting method.</p><p><b>RESULTS</b>No syncytium was formed by mixing HL2/3 and HeLa-CD4-LTR-beta-gal cells. However, the membrane could be fused and the Tat expressed by HL2/3 cells could bind to HIV LTR on HeLa-CD4-LTR-beta-gal cells and trigger the expression of beta-galactosidase. CPRG allowed quantitative and sensitive detection of the activity of beta-galactosidase. Further studies showed that HIV entry inhibitors could inhibit the activity of beta-galactosidase in a dose-dependent manner.</p><p><b>CONCLUSION</b>We have developed a simple, cheap, objective and quantitative non-infectious cell-cell fusion bioassay that can be used to screen for anti-HIV agents targeting the virus entry from natural and synthetic compound libraries.</p>


Subject(s)
Humans , Biological Assay , Cell Fusion , Cell Line , Coculture Techniques , Drug Evaluation, Preclinical , Methods , HIV Envelope Protein gp120 , Metabolism , HIV Envelope Protein gp41 , Metabolism , HIV Fusion Inhibitors , Chemistry , Pharmacology , beta-Galactosidase , Metabolism
5.
Journal of Southern Medical University ; (12): 1127-1131, 2008.
Article in Chinese | WPRIM | ID: wpr-270195

ABSTRACT

<p><b>OBJECTIVE</b>To observe the inhibitory effect of 1,2,6-Tri-O-galloyl-beta-D-glucopyranose (TGGP) from Balanophora japonica Makino on human immunodeficiency virus (HIV) entry into the host cells and explore the mechanisms.</p><p><b>METHODS</b>TGGP was purified from Balanophora japonica Makino by n-hexane and ethyl acetate extraction and column chromatography. The inhibitory activity of TGGP on HIV gp41 six-helix bundle formation was measured with ELISA, N-PAGE and SE-HPLC, and the inhibitory effect of TGGP on HIV envelope grlycoprotein-induced cell-cell fusion was detected using a non-infectious cell-based assay.</p><p><b>RESULTS</b>TGGP inhibited HIV gp41 six-helix bundle formation, with an IC50 of 1.37-/+0.19 microg/ml as determined by ELISA, and this activity was further confirmed by N-PAGE and SE-HPLC. TGGP at 25 microg/ml significantly inhibited syncytium formation between the effector (CHO-WT) and the target (MT-2) cells.</p><p><b>CONCLUSION</b>The HIV transmembrane subunit gp41 mediates the entry of HIV into the target cells. TGGP can inhibit HIV fusion and entry into the target cells by inhibiting the formation of gp41 six-helix bundles, suggesting the potential of TGGP as a microbicide to prevent sexual transmission of HIV.</p>


Subject(s)
Humans , Anti-HIV Agents , Pharmacology , Cell Membrane , Metabolism , HIV Envelope Protein gp41 , Metabolism , HIV Fusion Inhibitors , Pharmacology , HIV-1 , Metabolism , Hydrolyzable Tannins , Pharmacology , Membrane Fusion
SELECTION OF CITATIONS
SEARCH DETAIL